175 related articles for article (PubMed ID: 21537025)
1. Novel diamidines with activity against Babesia divergens in vitro and Babesia microti in vivo.
Nehrbass-Stuedli A; Boykin D; Tidwell RR; Brun R
Antimicrob Agents Chemother; 2011 Jul; 55(7):3439-45. PubMed ID: 21537025
[TBL] [Abstract][Full Text] [Related]
2. Artesunate, a potential drug for treatment of Babesia infection.
Goo YK; Terkawi MA; Jia H; Aboge GO; Ooka H; Nelson B; Kim S; Sunaga F; Namikawa K; Igarashi I; Nishikawa Y; Xuan X
Parasitol Int; 2010 Sep; 59(3):481-6. PubMed ID: 20541037
[TBL] [Abstract][Full Text] [Related]
3. Ellagic acid microspheres restrict the growth of Babesia and Theileria in vitro and Babesia microti in vivo.
Beshbishy AM; Batiha GE; Yokoyama N; Igarashi I
Parasit Vectors; 2019 May; 12(1):269. PubMed ID: 31138282
[TBL] [Abstract][Full Text] [Related]
4. 17-DMAG inhibits the multiplication of several Babesia species and Theileria equi on in vitro cultures, and Babesia microti in mice.
Guswanto A; Nugraha AB; Tuvshintulga B; Tayebwa DS; Rizk MA; Batiha GE; Gantuya S; Sivakumar T; Yokoyama N; Igarashi I
Int J Parasitol Drugs Drug Resist; 2018 Apr; 8(1):104-111. PubMed ID: 29499568
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy against babesiosis.
Vial HJ; Gorenflot A
Vet Parasitol; 2006 May; 138(1-2):147-60. PubMed ID: 16504402
[TBL] [Abstract][Full Text] [Related]
6. The effects of trans-chalcone and chalcone 4 hydrate on the growth of Babesia and Theileria.
Batiha GE; Beshbishy AM; Tayebwa DS; Adeyemi OS; Shaheen H; Yokoyama N; Igarashi I
PLoS Negl Trop Dis; 2019 May; 13(5):e0007030. PubMed ID: 31125333
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy of Babesia microti infections in Mongolian Jirds.
Ruebush TK; Contacos PG; Steck EA
Antimicrob Agents Chemother; 1980 Aug; 18(2):289-91. PubMed ID: 7447406
[TBL] [Abstract][Full Text] [Related]
8. Compounds from the Medicines for Malaria Venture Box Inhibit In Vitro Growth of
Rizk MA; El-Sayed SAE; Alkhoudary MS; Alsharif KF; Abdel-Daim MM; Igarashi I
Molecules; 2021 Nov; 26(23):. PubMed ID: 34885700
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the in vitro and in vivo inhibitory effect of thymoquinone on piroplasm parasites.
El-Sayed SAE; Rizk MA; Yokoyama N; Igarashi I
Parasit Vectors; 2019 Jan; 12(1):37. PubMed ID: 30651142
[TBL] [Abstract][Full Text] [Related]
10. Therapy trial using betamethasone in addition to specific treatment with a diamidine and quinuronium derivate in cattle experimentally infected with Babesia bigemina.
Löhr FK; Otieno PS; Gacanga W
Bull Anim Health Prod Afr; 1976 Jun; 24(2):199-205. PubMed ID: 16300142
[No Abstract] [Full Text] [Related]
11. Babesia microti infection, eastern Pennsylvania, USA.
Acosta ME; Ender PT; Smith EM; Jahre JA
Emerg Infect Dis; 2013 Jul; 19(7):1105-7. PubMed ID: 23764008
[TBL] [Abstract][Full Text] [Related]
12. Clofazimine, a Promising Drug for the Treatment of Babesia microti Infection in Severely Immunocompromised Hosts.
Tuvshintulga B; Vannier E; Tayebwa DS; Gantuya S; Sivakumar T; Guswanto A; Krause PJ; Yokoyama N; Igarashi I
J Infect Dis; 2020 Aug; 222(6):1027-1036. PubMed ID: 32310272
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of allicin on the growth of Babesia and Theileria equi parasites.
Salama AA; AbouLaila M; Terkawi MA; Mousa A; El-Sify A; Allaam M; Zaghawa A; Yokoyama N; Igarashi I
Parasitol Res; 2014 Jan; 113(1):275-83. PubMed ID: 24173810
[TBL] [Abstract][Full Text] [Related]
14. Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection.
Wormser GP; Prasad A; Neuhaus E; Joshi S; Nowakowski J; Nelson J; Mittleman A; Aguero-Rosenfeld M; Topal J; Krause PJ
Clin Infect Dis; 2010 Feb; 50(3):381-6. PubMed ID: 20047477
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of a strain of Babesia gibsoni resistant to diminazene aceturate in vitro.
Hwang SJ; Yamasaki M; Nakamura K; Sasaki N; Murakami M; Wickramasekara Rajapakshage BK; Ohta H; Maede Y; Takiguchi M
J Vet Med Sci; 2010 Jun; 72(6):765-71. PubMed ID: 20160418
[TBL] [Abstract][Full Text] [Related]
16. Babesia bigemina: in vitro and in vivo effects of curdlan sulfate on growth of parasites.
Igarashi I; Njonge FK; Kaneko Y; Nakamura Y
Exp Parasitol; 1998 Nov; 90(3):290-3. PubMed ID: 9806875
[No Abstract] [Full Text] [Related]
17. Could the Drug Tafenoquine Revolutionize Treatment of Babesia microti Infection?
Mordue DG; Wormser GP
J Infect Dis; 2019 Jul; 220(3):442-447. PubMed ID: 31099380
[TBL] [Abstract][Full Text] [Related]
18. Combination of Clofazimine and Atovaquone as a Potent Therapeutic Regimen for the Radical Cure of Babesia microti Infection in Immunocompromised Hosts.
Tuvshintulga B; Sivakumar T; Nugraha AB; Ahedor B; Batmagnai E; Otgonsuren D; Liu M; Xuan X; Igarashi I; Yokoyama N
J Infect Dis; 2022 Jan; 225(2):238-242. PubMed ID: 34664651
[TBL] [Abstract][Full Text] [Related]
19. In vivo antibabesial activity and bioinformatic analysis of compounds derived from the Medicines for Malaria Venture box against Babesia microti.
Rizk MA; El-Sayed SAE; Eltaysh R; Igarashi I
Mol Biochem Parasitol; 2022 Jan; 247():111444. PubMed ID: 34933065
[TBL] [Abstract][Full Text] [Related]
20. [Light and electron microscopy studies of the developmental cycle and effect of pentamidine on the morphology of intra-erythrocyte stages of Babesia microti].
Mehlhorn H; Raether W; Schein E; Weber M; Uphoff M
Dtsch Tierarztl Wochenschr; 1986 Oct; 93(9):400-5. PubMed ID: 3536409
[No Abstract] [Full Text] [Related]
[Next] [New Search]
